Mammoth Biosciences gets funding to develop Crispr based tests to detect biological threats. Company’s CEO, Trevor Martin, says his goal is to develop an easy-to-use and a cost effective test which could be easily accessible.
Under 30 Alum Mammoth Biosciences To Develop Diagnostics For Department Of Defense
